AbbVie Inc. (ABBV) was held by 50 of the 148 most recent 13F filings reviewed for the 03/31/2026 reporting period. The article is a snapshot of hedge fund ownership and suggests ABBV remains a relatively widely held healthcare name. No performance, guidance, or business update is provided, so the market impact is limited.
AbbVie Inc. (ABBV) was held by 50 of the 148 most recent 13F filings reviewed for the 03/31/2026 reporting period. The article is a snapshot of hedge fund ownership and suggests ABBV remains a relatively widely held healthcare name. No performance, guidance, or business update is provided, so the market impact is limited.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment